Picture of Mauna Kea Technologies SA logo

ALMKT — Mauna Kea Technologies SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Mauna Kea Updates On Cellvizio In Detection Of Esophageal Dysplasia And Cancer

July 6 (Reuters) - Mauna Kea Technologies SAS  MKEA.PA :
    * PUBLICATION OF METAANALYSIS DEMONSTRATING SIGNIFICANT ROLE
OF
CELLVIZIO IN DETECTION OF ESOPHAGEAL DYSPLASIA AND CANCER
    * RESULTS DEMONSTRATE SIGNIFICANT INCREASE IN DETECTION RATE
OF
NEOPLASIA WHEN CELLVIZIO IS USED AS ADJUNCT TO STANDARD
DIAGNOSTIC METHOD, HIGHLIGHTING KEY ROLE OF ADVANCED IMAGING IN
FIGHT AGAINST DEVELOPMENT RAPID ESOPHAGEAL CANCER

Further company coverage:  MKEA.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Mauna Kea Technologies SA

See all news